GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Profiles / Sofia Cortes
  • +351 213 652 600
  • +351 213 632 105
  • Send Mail
  • Download CV
  • Orcid
  • NOVA Research

Sofia Cortes

Assistant Researcher

GHTM Group: VBD PhD members, Vector-borne diseases

ProfileResearchTop 5 Publications

Presently I am Assistant Researcher in Research and Teaching Unit of Medical Parasitology at Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (NOVA, Lisbon, Portugal) and member of the Vector-Borne Diseases (VBD) group of the of Global Health and Tropical Medicine Research Center (GHTM) hosted at IHMT. I have a degree in Biology and a PhD in Biomedical Sciences, Parasitology (UNL).

In 2014, I was awarded with a two-year Marie Sklodowska-Curie grant at TH Wildau, Germany, focusing on phenotypic, proteomic, and spectrometric characterization and differentiation of Leishmania hybrids and search for biomarkers. Later, in 2017, in line with previous interests and research on drug discovery for leishmaniasis, I was awarded with an FCT Investigator starting grant focusing on studies to find active compounds against Leishmania sp.

Recently, in 2021, through support of pharmaceutical Industry (MSD Animal Health and LETI Pharma), I was the PI of a national project on canine leishmaniosis to update the seroepidemiological status of the disease in Portugal and determine its risk factors. To date I have participated in 14 international (EU/FP6, EU/FP7, BMBF) and national (FCT, Pharma Insdustry) research projects, 4 as principal Investigator and 2 international networks. I am author/ co-author of 1 book chapter, 46 publications. I also teach in national and international universities and coordinate two curricular units in Leishmaniasis and Cell culture applications under the Medical Parasitology and Biomedical Sciences Masters at NOVA IHMT.

My research topics and interests fall within Medical and Health Sciences with emphasis on Parasitology. My main outputs are related to human and canine leishmaniasis, Leishmania drug susceptibility and drug development, diagnosis, host-parasite interactions, molecular epidemiology, and population genetics and canine leishmaniosis.

 

 

  1. Kastner B, Marschall M, Hornemann A, Metzner S, Patoka P, Cortes S, Wubbeler G, Hoehl A, Ruhl E, Elster C. 2024. Compressed AFM-IR hyperspectral nanoimaging. Mesurement Science and Technology. 35, 015403. https://doi.org/10.1088/1361-6501/acfc27
  2. Mendes A, Armada A, Cabral LIL, Amado PSM, Campino L, Cristiano MLS, Cortes S. 1,2,4-trioxolane and 1,2,4,5-tetraoxane endoperoxides against Old-World Leishmania parasites: in vitro activity and mode of action. 2022. Pharmaceuticals. 15, 446. https://doi.org/10.3390/ph15040446
  3. Kuhls K, Moskalenko O, Sukiasyan A, Manukyan D, Melik-Andreasyan G, Atshemyan L, Apresyan H, Strelkova M, Jaeschke A, Wieland R, Frohme M, Cortes S, Keshishyan A. 2021. Microsatellite based molecular epidemiology of Leishmania infantum from re-emerging foci of visceral leishmaniasis in Armenia and pilot risk assessment by ecological niche modelling. PLOS Negl Trop Dis.15(4): e0009288. https://doi.org/10.1371/journal.pntd.0009288
  4. Cortes S, Albuquerque-Wendt A, Maia C, Carvalho M, Lima I, De Freitas L., Campino L. 2019. Elucidating in vitro and in vivo phenotypic behaviour of L. infantum/L. major natural hybrids. Parasitol, 146: 580–587. https://doi.org/10.1017/S0031182018001993
  5. Cortes S, Albuquerque A, Cabral L, Lopes L, Campino L, Cristiano MLS. 2015. In vitro susceptibility of Leishmania infantum to Artemisinin derivatives and selected trioxolanes. Antimicrobiol Agents Chemother. 59 (8), 5032-35. DOI: 10.1128/AAC.00298-15.

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok